{"transactions":[{"id":4633287,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-10-01T16:00:03.000Z","date":"2026-10-01","kind":"exercise","planned":false,"acquired":false,"shares":921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026."}],"balance_after":1843,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":921},"source":{"system":"sec-edgar","filing":"0001193125-26-409855","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526409855/ownership.xml","form_type":"4"}},{"id":4633286,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-01T16:00:03.000Z","date":"2026-10-01","kind":"exercise","planned":false,"acquired":true,"shares":921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the issuer's Common Stock."}],"balance_after":1843,"source":{"system":"sec-edgar","filing":"0001193125-26-409855","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526409855/ownership.xml","form_type":"4"}},{"id":721877,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-01T20:30:21.000Z","date":"2026-07-01","kind":"exercise","planned":false,"acquired":false,"shares":922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026."}],"balance_after":2764,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":922},"source":{"system":"sec-edgar","filing":"0001193125-26-292644","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526292644/ownership.xml","form_type":"4"}},{"id":721876,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T20:30:21.000Z","date":"2026-07-01","kind":"exercise","planned":false,"acquired":true,"shares":922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the issuer's Common Stock."}],"balance_after":922,"source":{"system":"sec-edgar","filing":"0001193125-26-292644","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526292644/ownership.xml","form_type":"4"}},{"id":775704,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-18T20:11:53.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":3686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest monthly over 12 months from the grant date in substantially equal monthly increments, provided that the options vest in full on the Issuer's 2027 Annual Stockholder Meeting, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting."}],"balance_after":3686,"derivative":{"exercise_price":5.76,"expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":3686},"source":{"system":"sec-edgar","filing":"0001193125-26-228929","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526228929/ownership.xml","form_type":"4"}},{"id":775703,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-18T20:11:53.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":3686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs awarded vest ratably over four quarters in substantially equal 1/4th increments, commencing with 1/4th vesting on July 1, 2026 and the remainder vesting quarterly thereafter."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs awarded vest ratably over four quarters in substantially equal 1/4th increments, commencing with 1/4th vesting on July 1, 2026 and the remainder vesting quarterly thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs awarded vest ratably over four quarters in substantially equal 1/4th increments, commencing with 1/4th vesting on July 1, 2026 and the remainder vesting quarterly thereafter."}],"balance_after":3686,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3686},"source":{"system":"sec-edgar","filing":"0001193125-26-228929","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526228929/ownership.xml","form_type":"4"}},{"id":1065802,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-15T20:29:13.000Z","date":"2025-08-13","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest monthly over 24 months from the Grant Date in substantially equal monthly installments."}],"balance_after":40000,"derivative":{"exercise_price":0.5744,"expiration_date":"2035-08-12","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000950170-25-109414","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000095017025109414/ownership.xml","form_type":"4"}},{"id":1065801,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-15T20:29:13.000Z","date":"2025-08-13","kind":"grant","planned":false,"acquired":true,"shares":297794,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's 2026 Annual Stockholder Meeting, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting."}],"balance_after":297794,"derivative":{"exercise_price":0.5744,"expiration_date":"2035-08-12","underlying":"Common Stock","underlying_shares":297794},"source":{"system":"sec-edgar","filing":"0000950170-25-109414","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000095017025109414/ownership.xml","form_type":"4"}},{"id":1969004,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"officer":true,"officer_title":"CFO, Gen Counsel and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-06T21:10:36.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":557900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable on a quarterly basis over 24 months from the grant-date."}],"balance_after":557900,"derivative":{"exercise_price":0.72,"expiration_date":"2033-03-02","underlying":"Common Stock","underlying_shares":557900},"source":{"system":"sec-edgar","filing":"0001437749-23-005531","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774923005531/rdgdoc.xml","form_type":"4"}},{"id":2368967,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"officer":true,"officer_title":"CFO, Gen Counsel and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-28T22:15:57.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":746667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest on a quarterly basis over two (2) years."}],"balance_after":746667,"derivative":{"exercise_price":1.25,"expiration_date":"2032-02-24","underlying":"Common Stock","underlying_shares":746667},"source":{"system":"sec-edgar","filing":"0001437749-22-004668","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774922004668/rdgdoc.xml","form_type":"4"}},{"id":2708036,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"officer":true,"officer_title":"CFO, Gen Counsel and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2021-05-18T20:18:45.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":850000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest on a quarterly basis over the next 24 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2021 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant."}],"balance_after":850000,"derivative":{"exercise_price":2.9,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":850000},"source":{"system":"sec-edgar","filing":"0001437749-21-012675","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774921012675/rdgdoc.xml","form_type":"4"}},{"id":3177925,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"officer":true,"officer_title":"CFO, Gen Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-13T22:21:03.000Z","date":"2020-04-09","kind":"grant","acquired":true,"shares":395000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest quarterly in equal amounts over two years from the grant date (April 9, 2020), subject to continued employment with the Company through the applicable vesting dates.  However, 50% of all then-unvested options will vest immediately upon the achievement of certain milestones. The stock options are also subject to stockholder approval of the 2020 Stock Incentive Plan of the Company, which approval must occur within one year from the grant date."}],"balance_after":395000,"derivative":{"exercise_price":1.48,"expiration_date":"2030-04-09","underlying":"Common Shares","underlying_shares":395000},"source":{"system":"sec-edgar","filing":"0001437749-20-007630","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774920007630/rdgdoc.xml","form_type":"4"}},{"id":3177924,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"officer":true,"officer_title":"CFO, Gen Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-13T22:21:03.000Z","date":"2020-04-09","kind":"grant","acquired":true,"shares":195000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest quarterly in equal amounts over two years from the grant date (April 9, 2020), subject to continued employment with the Company through the applicable vesting dates."}],"balance_after":195000,"derivative":{"exercise_price":1.48,"expiration_date":"2030-04-09","underlying":"Common Shares","underlying_shares":195000},"source":{"system":"sec-edgar","filing":"0001437749-20-007630","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774920007630/rdgdoc.xml","form_type":"4"}},{"id":3695496,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Gen Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-15T21:10:29.000Z","date":"2019-01-13","kind":"grant","acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The June 27, 2018 options are being rescinded and a new option is being granted in order to: (i) impose a shareholder-approval requirement for the new option grant, and (ii) remove the cash settlement feature and associated liability from the June 27, 2018 grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to stockholder approval of the option grant, the option will vest and be exercisable with respect to: (i) 25% of the underlying shares as of the grant date (January 13, 2019), (ii) 50% of the underlying shares over a two-year period (vesting ratably quarterly) from June 27, 2018, and (iii) 25% of the underlying shares upon achievement of certain milestones. If the option grant is not approved by stockholders, then the option will not be exercisable."}],"balance_after":800000,"derivative":{"exercise_price":1.36,"expiration_date":"2029-01-13","underlying":"Common Shares","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001615774-19-000644","document":"s115378_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577419000644/s115378_form4.xml","form_type":"4"}},{"id":3695495,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Gen Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-15T21:10:29.000Z","date":"2019-01-13","kind":"disposition_to_issuer","acquired":false,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The June 27, 2018 options are being rescinded and a new option is being granted in order to: (i) impose a shareholder-approval requirement for the new option grant, and (ii) remove the cash settlement feature and associated liability from the June 27, 2018 grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent of the options were vested as of the grant date (June 27, 2018), 50% of the options will vest quarterly over two years from the grant date, and the remaining 25% will vest upon achievement of certain milestones."}],"balance_after":0,"derivative":{"exercise_price":2.38,"expiration_date":"2028-06-27","underlying":"Common Shares","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001615774-19-000644","document":"s115378_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577419000644/s115378_form4.xml","form_type":"4"}},{"id":3880465,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Gen Counsel and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-29T20:04:29.000Z","date":"2018-06-27","kind":"grant","acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the options have vested as of the grant date, 50% of the options will vest quarterly over two years, and the remaining 25% will vest upon achievement of certain milestones."}],"balance_after":700000,"derivative":{"exercise_price":2.38,"expiration_date":"2028-06-27","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001615774-18-006001","document":"s111134_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577418006001/s111134_form4.xml","form_type":"4"}},{"id":3912508,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Gen Counsel and Secretary"}}],"security":"Warrants","published_at":"2018-05-31T19:24:48.000Z","date":"2018-05-30","kind":"purchase","acquired":true,"shares":2272,"price":1000,"value":2272000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Shares of Series B Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series B Convertible Preferred Stock and 284 Warrants."}],"balance_after":2272,"derivative":{"exercise_price":4.05,"exercise_date":"2018-05-30","expiration_date":"2022-05-30","underlying":"Common Stock","underlying_shares":2272},"source":{"system":"sec-edgar","filing":"0001615774-18-004655","document":"s110545_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577418004655/s110545_form4.xml","form_type":"4"}},{"id":3912507,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Gen Counsel and Secretary"}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-05-31T19:24:48.000Z","date":"2018-05-30","kind":"purchase","acquired":true,"shares":8,"price":1000,"value":8000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Convertible Preferred Stock is convertible into the number of shares of Common Stock equal to the stated value of $1,000 divided by $3.52."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Shares of Series B Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series B Convertible Preferred Stock and 284 Warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of Series B Convertible Preferred Stock do not expire."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"No fractional shares will be issued upon conversion. At its election, the Company will either issue a cash adjustment or round up to the next whole share. The number reflected here assumes rounding up to the next whole share."}],"balance_after":8,"derivative":{"exercise_price":3.52,"exercise_date":"2018-05-30","underlying":"Common Stock","underlying_shares":2273},"source":{"system":"sec-edgar","filing":"0001615774-18-004655","document":"s110545_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577418004655/s110545_form4.xml","form_type":"4"}},{"id":4160466,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Gen Counsel and Secretary"}}],"security":"Common Stock","published_at":"2017-11-16T11:03:54.000Z","date":"2017-11-15","kind":"purchase","acquired":true,"shares":1400,"price":0.3365,"value":471.1,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001615774-17-006777","document":"s108207_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577417006777/s108207_form4.xml","form_type":"4"}},{"id":4160465,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Gen Counsel and Secretary"}}],"security":"Common Stock","published_at":"2017-11-16T11:03:54.000Z","date":"2017-11-15","kind":"purchase","acquired":true,"shares":8600,"price":0.337,"value":2898.2,"ownership":{"direct":true},"balance_after":8600,"source":{"system":"sec-edgar","filing":"0001615774-17-006777","document":"s108207_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577417006777/s108207_form4.xml","form_type":"4"}},{"id":4302948,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":34213,"kind":"person","name":"Guse Kyle","position":1,"cik":"0001566618","reported_name":"Guse Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Gen Counsel and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2017-05-26T17:46:08.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":495333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 48 months."}],"balance_after":640667,"derivative":{"exercise_price":0.47,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":495333},"source":{"system":"sec-edgar","filing":"0001615774-17-002741","document":"s106362_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577417002741/s106362_form4.xml","form_type":"4"}}]}